TRAIL及其受体在PCOS病人卵巢颗粒细胞表达(5)
[21]DUFOUR F， RATTIER T， CONSTANTINESCU A A， et al. Molecular mechanisms of TRAILinduced apoptosis of cancer cells[J]. Chinese Science Bulletin， 2001，8(9)：707709.
[22]張娟，朱桂金，王昕荣，等. Apoptosis and expression of protein TRAIL in granulosa cells of rats with polycystic ovarian syndrome[J]. Journal of Huazhong University of Science and TechnologyMedical Sciences， 2007，27(3)：311314.
[23]RULL K， TOMBERG K， KK K K， et al. Human soluble TRAIL protein inducing apoptosis in osteosarcoma cell[J]. Wuhan University Journal of Natural Sciences， 2007，34(6)：11481152.
[24]BARAKONYI A， MIKO E， SZEREDAY L， et al. Cell death mechanisms and potentially cytotoxic natural immune cells in human pregnancies complicated by preeclampsia[J]. Reproductive Sciences (Thousand Oaks， Calif.)， 2014，21(2)：155166.
[HJ2mm]
[25]CARTLAND S P， HARITH H H， GENNER S W， et al. Nonalcoholic fatty liver disease， vascular inflammation and insulin resistance are exacerbated by TRAIL deletion in mice[J]. Scientific Reports， 2017，7(1)：18981907.
[26]HARPER E， FORDE H， DAVENPORT C， et al. Vascular calcification in type2 diabetes and cardiovascular disease： integrative roles for OPG， RANKL and TRAIL[J]. Vascular Pharmacology， 2016，82：3040
[27]PASARIN M， ABRALDES J G， LIGUORI E et al. Intrahepatic vascular changes in nonalcoholic fatty liver disease： potential role of insulinresistance and, 百拇医药(李科 祁秀娟 吕映频 谭慧芳 苗佳)
[22]張娟，朱桂金，王昕荣，等. Apoptosis and expression of protein TRAIL in granulosa cells of rats with polycystic ovarian syndrome[J]. Journal of Huazhong University of Science and TechnologyMedical Sciences， 2007，27(3)：311314.
[23]RULL K， TOMBERG K， KK K K， et al. Human soluble TRAIL protein inducing apoptosis in osteosarcoma cell[J]. Wuhan University Journal of Natural Sciences， 2007，34(6)：11481152.
[24]BARAKONYI A， MIKO E， SZEREDAY L， et al. Cell death mechanisms and potentially cytotoxic natural immune cells in human pregnancies complicated by preeclampsia[J]. Reproductive Sciences (Thousand Oaks， Calif.)， 2014，21(2)：155166.
[HJ2mm]
[25]CARTLAND S P， HARITH H H， GENNER S W， et al. Nonalcoholic fatty liver disease， vascular inflammation and insulin resistance are exacerbated by TRAIL deletion in mice[J]. Scientific Reports， 2017，7(1)：18981907.
[26]HARPER E， FORDE H， DAVENPORT C， et al. Vascular calcification in type2 diabetes and cardiovascular disease： integrative roles for OPG， RANKL and TRAIL[J]. Vascular Pharmacology， 2016，82：3040
[27]PASARIN M， ABRALDES J G， LIGUORI E et al. Intrahepatic vascular changes in nonalcoholic fatty liver disease： potential role of insulinresistance and, 百拇医药(李科 祁秀娟 吕映频 谭慧芳 苗佳)